Similar Papers

Paper Title
Journal
Date
Author
Novel therapies for multiple myeloma.
Toshiaki Hayashi ... Kenneth C Anderson
British Journal of Haematology | VOL. 120
Toshiaki Hayashi, et. al.Toshiaki Hayashi ... Kenneth C Anderson
20 Dec 2002
Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions
Kenneth C Anderson
Experimental Hematology | VOL. 35
Kenneth C AndersonKenneth C Anderson
28 Mar 2007
Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules
Marina Bolzoni ... Nicola Giuliani
Experimental Hematology | VOL. 41
Marina Bolzoni, et. al.Marina Bolzoni ... Nicola Giuliani
22 Nov 2012
Author response: Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling
Mariah Farrell ... Carolyne Falank
-
Mariah Farrell, et. al.Mariah Farrell ... Carolyne Falank
01 Feb 2023
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Advances in RNA editing in hematopoiesis and associated malignancies.
Shuangshuang Pu ... Hui Cheng
Blood | VOL. -
Shuangshuang Pu, et. al.Shuangshuang Pu ... Hui Cheng
27 Jan 2025
Protection of β2GPI-Deficient Mice from Thrombosis Reflects a Defect in PAR3-facilitated Platelet Activation.
Paresh P Kulkarni ... Keith R Mccrae
Blood | VOL. -
Paresh P Kulkarni, et. al.Paresh P Kulkarni ... Keith R Mccrae
27 Jan 2025
Babesiosis and Sickle Red blood Cells: Loss of Deformability, Heightened Osmotic fragility, and Hypervesiculation.
Divya Beri ... Cheryl A Lobo
Blood | VOL. -
Divya Beri, et. al.Divya Beri ... Cheryl A Lobo
27 Jan 2025
Platelet activation and signaling in thrombus formation.
Frauke Swieringa ... Alice Assinger
Blood | VOL. -
Frauke Swieringa, et. al.Frauke Swieringa ... Alice Assinger
27 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.